Lupus and COVID vaccines: immune response under the microscope
NCT ID NCT04894253
First seen Jun 27, 2026 · Last updated Jun 27, 2026
Summary
This study aimed to understand how the COVID-19 vaccine impacts the immune system in people with lupus, a chronic autoimmune disease. Researchers planned to enroll lupus patients to measure their immune response to the vaccine and see if lupus disease activity or treatments affected that response. The study was terminated early with only 7 participants enrolled, so results are limited.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for SYSTEMIC LUPUS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
University Hospital of Hautepierre
Strasbourg, Bas-Rhin, 67000, France
More trials for these conditions
Other studies related to the condition(s) this trial covers.